EX-23.1 5 pstx-ex231_6.htm EX-23.1 pstx-ex231_6.htm

 

Exhibit 23.1

 

 

 

CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

We hereby consent to the incorporation by reference in the Registration Statements on Form S-8 (No. 333-240048; No. 333-256899; No. 333-262869) and Form S-3 (No. 333-258804) of Poseida Therapeutics, Inc. of our report dated March 10, 2022 relating to the financial statements, which appears in this Form 10-K.

 

/s/ PricewaterhouseCoopers LLP

San Diego, California
March 10, 2022